CDX2 knockdown in colon cancer cells led to a decreased percentage of cells in the G0/G1 phase and an increased percentage in the S phase compared to the control (Fig. 4a, b, e, f, all P < 0.05). The gene discussed is CDX2; the disease is malignant colon neoplasm.